NUNAPS
Nunaps operates as a digital therapeutics startup.
NUNAPS
Industry:
Therapeutics
Founded:
2017-01-01
Address:
Seoul, Seoul-t'ukpyolsi, South Korea
Country:
South Korea
Website Url:
http://www.nunaps.co.kr
Total Employee:
1+
Status:
Closed
Total Funding:
4.2 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apple Mobile Web Clips Icon Content Delivery Network GStatic Google Static Content Wix SEO_H2
Similar Organizations
Healthwire
Healthwire is a health-tech startup.
Janpix
Janpix operates as an oncology-focused startup.
Werewolf Therapeutics
Werewolf Therapeutics operates as an oncology biotherapeutics company.
Current Employees Featured
Cho Kyu Sok Chief Financial Officer @ Nunaps
Chief Financial Officer
Lee Eun Jae Chief Medical Officer @ Nunaps
Chief Medical Officer
Hah Tae Hwan Chief Technology Officer @ Nunaps
Chief Technology Officer
Dong Wha Kang CEO @ Nunaps
CEO
2017-11-01
Investors List
KTB Network
KTB Network investment in Series A - Nunaps
K2 Investment Partners
K2 Investment Partners investment in Series A - Nunaps
Company K Partners
Company K Partners investment in Series A - Nunaps
Official Site Inspections
http://www.nunaps.co.kr
- Host name: 27.96.134.144
- IP address: 27.96.134.144
- Location: South Korea
- Latitude: 37.5112
- Longitude: 126.9741
- Timezone: Asia/Seoul
More informations about "Nunaps"
Nunaps - 혁신의료기기 선두주자, 뉴냅스
뉴냅스는 디지털 치료제 (Digital Therapeutics, DTx) 전문 기업으로 뇌질환 환자의 삶의 질 향상을 목표로 하고 있습니다. 신경과학, 심리학, 인공지능, 소프트웨어 엔지니어 등 다양한 분야의 …See details»
Nunaps - Crunchbase Company Profile & Funding
Where is Nunaps's headquarters? Nunaps is located in Seoul, Seoul-t'ukpyolsi, South Korea. Who invested in Nunaps? Nunaps has 5 investors including KTB …See details»
혁신의료기기 선두주자, 뉴냅스 - Nunaps
서울특별시 송파구 올림픽로 43길 88 아산생명과학연구원 융합연구관 11층 1호 (풍납동, 서울아산병원)See details»
Nunaps Inc. Company Profile | Seoul, Seoul, Republic Of Korea ...
Find company research, competitor information, contact details & financial data for Nunaps Inc. of Seoul, Seoul. Get the latest business insights from Dun & Bradstreet.See details»
Nunaps 2025 Company Profile: Valuation, Funding & Investors
Information on valuation, funding, cap tables, investors, and executives for Nunaps. Use the PitchBook Platform to explore the full profile.See details»
Nunaps Company Profile - Office Locations, Competitors, Revenue …
Nunaps $4.2 m in total funding,. See insights on Nunaps including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Nunaps - Funding, Financials, Valuation & Investors - Crunchbase
Nunaps is funded by 5 investors. KTB Network and K2 Investment Partners are the most recent investors.See details»
nunaps - Company Introduction
뉴냅스는 신경과학, 심리학, 인공지능, 소프트웨어 엔지니어, 임상인허가팀 등 다학제 융합연구개발진으로 이루어진 기업입니다. 뉴냅스의 연구개발은 기존 치료법이 없거나 …See details»
Nunaps - Company Profile - Tracxn
Feb 21, 2025 Nunaps provides digital therapeutics software for brain damage. It is a software for VR devices that combines the theory of blindness that certain visual stimuli are transmitted to …See details»
Nunaps, Inc. (Nunaps, Inc.) - 药物管线_专利_临床试验_投融营收
Developed by local digital therapeutics company Nunaps, VIVID Brain is the first recognised South Korean DTx for improving visual impairment caused by brain damage. It provides visual …See details»
Nunaps - Products, Competitors, Financials, Employees, …
Nunaps focuses on developing digital therapeutics within the healthcare sector, specifically targeting brain disorders. The company's main offerings include a platform for identifying …See details»
Nunaps Inc. - Overview, News & Similar companies | ZoomInfo.com
View Nunaps Inc. (www.nunaps.co.kr) location in Seoul, South Korea , revenue, industry and description. Find related and similar companies as well as employees by title and much more.See details»
Nunaps, Inc.: Drug pipelines, Patents, Clinical trials - Synapse
Explore Nunaps, Inc. with its drug pipeline, therapeutic area, technology platform, 4 clinical trials, 2 news, and 10 literature.See details»
用 VR 技术治疗由脑部损伤而导致的视觉障碍，韩国初创公司 …
近日，韩国数字治疗初创公司「Nunaps」 完成了 50 亿韩元（420万美元）的 A 轮融资，此轮融资 由 K Partners、KTB Network 和 K2 Investment Partners 公司投资。See details»
Dong-Wha Kang님 - Founder & CEO - Nunaps | LinkedIn
Founder & CEO, Nunaps / Professor of Neurology, Asan Medical Center · Nunaps, Neuroscience-based Digital Therapeutics Startup · Nunaps · 서울대학교 (Seoul National University) · 서울 · …See details»
Nunaps - Contacts, Employees, Board Members, Advisors
Nunaps has 4 current employee profiles, including Chief Financial Officer Cho Kyu Sok.Nunaps operates as a digital therapeutics startup.See details»
Nunaps Bags $4.2M to Build Digital Therapeutics Platform
Jan 17, 2020 Nunaps is the pioneering digital therapeutics organization in Korea and has the potential to become a global top-tier, establishing up clinical trials for new digital therapeutics …See details»
Nunaps develops the 1st Digital Therapeutics in Korea
Dec 20, 2019 Nunaps is a start-up founded in November 2017 by President Kang dong-wha, Professor of Neurology at Ulsan Medical College and Asan Medical Center and in charge of …See details»
South Korean startup raises $4.2M to trial VR therapy for brain …
Jan 6, 2020 A South Korean startup has raised 5 billion won, or about $4.2 million, to develop and test its software-based treatments for neurological disorders—after launching the first …See details»
Nunaps’ VR-based software designated as innovative medical
May 23, 2023 The Ministry of Food and Drug Safety (MFDS) said on Monday that it designated Nunaps’ virtual reality (VR)-based visual stimulation software as the nation’s 33rd innovative …See details»